Seelos Therapeutics Inc (NASDAQ:SEEL) Stock Sees Value Buying At Lower Level

August 23, 2021

Seelos Therapeutics Inc (NASDAQ:SEEL) jumped 12.5%after announcing its mid-year 2021 clinical and business update. CEO Raj Mehra said that the company continued executing at a high level in the year’s first half. Mehra said that part one of the company’s SLS-002 study showed immediate antisuicidal and antidepressant effects with an excellent tolerability profile. In addition, the company commenced part two of the placebo-controlled registration study planning to enroll patients in…

Read More >>